Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Inventory Average (2016 - 2025)

Guided Therapeutics' Inventory Average history spans 14 years, with the latest figure at $515500.0 for Q4 2025.

  • On a quarterly basis, Inventory Average fell 18.75% to $515500.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $515500.0, a 18.75% decrease, with the full-year FY2025 number at $540500.0, down 14.55% from a year prior.
  • Inventory Average hit $515500.0 in Q4 2025 for Guided Therapeutics, down from $589000.0 in the prior quarter.
  • Over the last five years, Inventory Average for GTHP hit a ceiling of $640000.0 in Q4 2023 and a floor of $515500.0 in Q4 2025.
  • Historically, Inventory Average has averaged $599475.0 across 5 years, with a median of $608000.0 in 2021.
  • Biggest five-year swings in Inventory Average: skyrocketed 1074.04% in 2021 and later decreased 18.75% in 2025.
  • Tracing GTHP's Inventory Average over 5 years: stood at $580500.0 in 2021, then decreased by 1.46% to $572000.0 in 2022, then grew by 11.89% to $640000.0 in 2023, then fell by 0.86% to $634500.0 in 2024, then decreased by 18.75% to $515500.0 in 2025.
  • Business Quant data shows Inventory Average for GTHP at $515500.0 in Q4 2025, $589000.0 in Q3 2025, and $614000.0 in Q2 2025.